Hillsdale Investment Management Inc. grew its position in Humana Inc (NYSE:HUM) by 18.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,890 shares of the insurance provider’s stock after buying an additional 300 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Humana were worth $461,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in HUM. Janus Henderson Group PLC boosted its holdings in shares of Humana by 7,848.8% during the second quarter. Janus Henderson Group PLC now owns 1,567,587 shares of the insurance provider’s stock worth $377,192,000 after purchasing an additional 1,547,866 shares during the period. FMR LLC boosted its holdings in shares of Humana by 29.3% during the second quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock worth $1,571,264,000 after purchasing an additional 1,479,210 shares during the period. Koch Industries Inc. acquired a new stake in shares of Humana during the second quarter worth approximately $404,000. TIAA CREF Investment Management LLC boosted its holdings in shares of Humana by 39.7% during the second quarter. TIAA CREF Investment Management LLC now owns 1,358,617 shares of the insurance provider’s stock worth $326,910,000 after purchasing an additional 386,162 shares during the period. Finally, Ameriprise Financial Inc. boosted its holdings in shares of Humana by 39.8% during the second quarter. Ameriprise Financial Inc. now owns 1,322,413 shares of the insurance provider’s stock worth $318,216,000 after purchasing an additional 376,177 shares during the period. Institutional investors own 94.18% of the company’s stock.

Several analysts recently commented on the stock. Credit Suisse Group decreased their price target on shares of Humana from $256.00 to $246.00 and set a “neutral” rating for the company in a report on Friday, November 10th. BMO Capital Markets raised their price target on shares of Humana from $290.00 to $300.00 and gave the stock an “outperform” rating in a report on Friday, November 10th. Morgan Stanley decreased their price target on shares of Humana from $276.00 to $270.00 and set an “overweight” rating for the company in a report on Thursday, November 9th. Royal Bank Of Canada restated a “sector perform” rating and set a $242.00 price target (down from $245.00) on shares of Humana in a report on Thursday, November 9th. Finally, Zacks Investment Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 17th. Thirteen investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Humana presently has an average rating of “Hold” and an average target price of $252.81.

Humana Inc (HUM) opened at $258.53 on Friday. The firm has a market cap of $37,260.05, a P/E ratio of 22.25, a P/E/G ratio of 1.79 and a beta of 0.88. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35. Humana Inc has a 52-week low of $186.25 and a 52-week high of $264.56.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating the consensus estimate of $3.27 by $0.12. The firm had revenue of $13.28 billion for the quarter, compared to analyst estimates of $13.41 billion. Humana had a net margin of 3.49% and a return on equity of 15.99%. The company’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter last year, the firm earned $3.18 earnings per share. equities analysts expect that Humana Inc will post 11.63 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio is 12.59%.

COPYRIGHT VIOLATION NOTICE: “Humana Inc (HUM) Holdings Lifted by Hillsdale Investment Management Inc.” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/02/humana-inc-hum-holdings-lifted-by-hillsdale-investment-management-inc.html.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related stocks with our FREE daily email newsletter.